The Broad Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

The Broad Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Broad Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
The Broad Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
45 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

The Broad Institute, Inc. (Broad Institute) is a non-profit research organization that meets critical challenges in biology and medicine. The institute transforms medicine by utilizing systematic approaches in biological sciences, to speed up the understanding and treatment of disease. It focuses on the discovery, development and optimization of technological tools that are needed to obtain and analyze massive amounts of genome-related data.

The Broad Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself wi

  
Source:
Document ID
GDPH142286D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
The Broad Institute, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
The Broad Institute, Inc., Medical Devices Deals, 2010 to YTD 2016101
The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016112
The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deal Details1329
  Partnerships131
    Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research131
    Broad Institute Genomic Services Partners with Takeda Pharma141
    Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform151
    Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies161
    AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute172
    Eisai Enters into Research Agreement with Broad Institute191
    Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics201
    EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute212
    Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery232
    Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis251
    Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy262
    AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents281
  Licensing Agreements291
    Albany Molecular Research Enters into Licensing Agreement with Broad Institute291
    Evotec Enters into Licensing Agreement with Broad Institute301
    Transposagen Biopharma Enters into Licensing Agreement with Broad Institute311
    Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital321
    Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System331
    GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System341
    Editas Medicine Enters into Licensing Agreement with Broad Institute of Harvard and MIT, and Harvard University352
    Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System371
    Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System381
    Applied Stemcell Enters into licensing Agreement with Broad Institute391
    Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System401
    ChemAxon Enters Into Licensing Agreement With Broad Institute Of Harvard And MIT411
The Broad Institute, Inc. - Key Competitors421
Key Employees431
Locations And Subsidiaries441
  Head Office441
  Other Locations &Subsidiaries441
Appendix451
  Methodology451
  About GlobalData451
  Contact Us451
  Disclaimer451

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "The Broad Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Broad-Institute-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17932>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). The Broad Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Broad-Institute-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17932>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research